Wellness Pharma International's Commitment The exact causes of many rare diseases remain elusive. While some can be traced to genetic mutations, environmental factors such as exposure to chemicals, smoking, and diet also play significant roles. Despite their rarity, these diseases require special medications, often referred to by the World Health Organization (WHO) as Orphan Drugs, Special Drugs, or Unlicensed Drugs. However, there is a significant challenge in ensuring the global availability and adequacy of these treatments.
Wellness Pharma International is dedicated to addressing this critical “unmet need” in the global market. As one of the few WHO Good Distribution Practices (GDP) certified distributors, we are committed to supporting patients and caregivers dealing with rare diseases by providing easy access to these essential medications. Our state-of-the-art infrastructure and professional operations enable us to deliver these medications worldwide effectively.
Get in Touch